<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Pediatric Hematology/Oncology and Immunopathology</journal-id><journal-title-group><journal-title xml:lang="en">Pediatric Hematology/Oncology and Immunopathology</journal-title><trans-title-group xml:lang="ru"><trans-title>Вопросы гематологии/онкологии и иммунопатологии в педиатрии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-1708</issn><issn publication-format="electronic">2414-9314</issn><publisher><publisher-name xml:lang="en">Fund Doctors, Innovations, Science for Children</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">434</article-id><article-id pub-id-type="doi">10.24287/1726-1708-2020-19-4-178-184</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>SCHOOL OF IMMUNOLOGY – EXPERT OPINION</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ШКОЛА ИММУНОЛОГА – МНЕНИЕ ЭКСПЕРТА</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Immune dysregulation symptoms as a rare manifestation of X-linked lymphoproliferative syndrome type 1</article-title><trans-title-group xml:lang="ru"><trans-title>Симптомы иммунной дисрегуляции как редкие проявления Х-сцепленного лимфопролиферативного синдрома 1-го типа</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5132-1267</contrib-id><name-alternatives><name xml:lang="en"><surname>Roppelt</surname><given-names>A. А.</given-names></name><name xml:lang="ru"><surname>Роппельт</surname><given-names>A. A.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><bold>Anna A. Roppelt</bold>, doctor in the Department of Immunology</p><p>1 Samory Mashela St., Moscow 117997 </p></bio><bio xml:lang="ru"><p><bold>Роппельт Анна Артуровна</bold>, врач отделения иммунологии </p><p>117997, Москва, ул. Саморы Машела, 1</p></bio><email>roppelt_anna@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6553-2505</contrib-id><name-alternatives><name xml:lang="en"><surname>Fadeeva</surname><given-names>M. S.</given-names></name><name xml:lang="ru"><surname>Фадеева</surname><given-names>M. C.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6148-7209</contrib-id><name-alternatives><name xml:lang="en"><surname>Pershin</surname><given-names>D. E.</given-names></name><name xml:lang="ru"><surname>Першин</surname><given-names>Д. Е.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2467-2840</contrib-id><name-alternatives><name xml:lang="en"><surname>Kieva</surname><given-names>A. М.</given-names></name><name xml:lang="ru"><surname>Киева</surname><given-names>А. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7634-2053</contrib-id><name-alternatives><name xml:lang="en"><surname>Raykina</surname><given-names>E. M.</given-names></name><name xml:lang="ru"><surname>Райкина</surname><given-names>Е. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3800-8927</contrib-id><name-alternatives><name xml:lang="en"><surname>Gutovskaya</surname><given-names>E. I.</given-names></name><name xml:lang="ru"><surname>Гутовская</surname><given-names>Е. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7696-1153</contrib-id><name-alternatives><name xml:lang="en"><surname>Radygina</surname><given-names>S. A.</given-names></name><name xml:lang="ru"><surname>Радыгина</surname><given-names>С. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3664-2876</contrib-id><name-alternatives><name xml:lang="en"><surname>Abramov</surname><given-names>D. S.</given-names></name><name xml:lang="ru"><surname>Абрамов</surname><given-names>Д. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3113-4939</contrib-id><name-alternatives><name xml:lang="en"><surname>Shcherbina</surname><given-names>A. Yu.</given-names></name><name xml:lang="ru"><surname>Щербина</surname><given-names>А. Ю.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр детской гематологии, онкологии и иммунологии им. Дмитрия Рогачева» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2020-12-08" publication-format="electronic"><day>08</day><month>12</month><year>2020</year></pub-date><volume>19</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>178</fpage><lpage>184</lpage><history><date date-type="received" iso-8601-date="2020-12-21"><day>21</day><month>12</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-12-21"><day>21</day><month>12</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2025, «D. Rogachev NMRCPHOI»</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2025, ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="en">«D. Rogachev NMRCPHOI»</copyright-holder><copyright-holder xml:lang="ru">ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://hemoncim.com/jour/article/view/434">https://hemoncim.com/jour/article/view/434</self-uri><abstract xml:lang="en"><p>X-linked lymphoproliferative syndrome type 1 (XLP1) is a primary immunodeficiency, the most dramatic manifestations of which are hemophagocytic lymphohistiocytosis (usually associated with Epstein-Barr virus), lymphoma and dysgammaglobulinemia. Immune symptoms like vasculitis, aplastic anemia and others are extremely rare. Specialists awareness and suspicion regarding such complications of XLP1 facilitate correct diagnosis and early curative treatment - hematopoietic stem cell transplantation (HSCT). Here we present two clinical cases of XLP1 with immune dysregulation symptoms where one patient underwent successful HSCT. In each case, the parents gave consent to the use of their child's data, including photographs, for research purposes and in publications.</p></abstract><trans-abstract xml:lang="ru"><p>Х-сцепленный лимфопролиферативный синдром 1-го типа (ХЛП1) – это первичный иммунодефицит, наиболее яркими проявлениями которого являются гемофагоцитарный лимфогистиоцитоз, как правило, ассоциированный с вирусом Эпштейна–Барр, лимфома и дисгаммаглобулинемия. Иммунные проявления, такие как васкулит, угнетение гемопоэза и др., встречаются крайне редко. Осведомленность и настороженность специалистов в отношении редких осложнений ХЛП1 способствуют правильной диагностике и своевременному проведению куративной терапии – трансплантации гемопоэтических стволовых клеток (ТГСК). Мы приводим два клинических случая ХЛП1 с проявлениями иммунной дисрегуляции, в одном из которых пациенту была проведена успешная ТГСК. Родители дали согласие на использование информации, в том числе фотографий детей, в научных исследованиях и публикациях.</p></trans-abstract><kwd-group xml:lang="en"><kwd>primary immunodeficiency</kwd><kwd>X-linked lymphoproliferative syndrome</kwd><kwd>SH2D1A gene</kwd><kwd>vasculitis</kwd><kwd>cytopenia</kwd><kwd>aplastic anemia</kwd><kwd>inflammatory bowel disease</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>первичный иммунодефицит</kwd><kwd>Х-сцепленный лимфопролиферативный синдром</kwd><kwd>ген SH2D1A</kwd><kwd>васкулит</kwd><kwd>цитопения</kwd><kwd>угнетение гемопоэза</kwd><kwd>воспалительное заболевание кишечника</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Coffey A.J., Brooksbank R.A., Brandau O., Oohashi T., Howell G.R., Bye J.M., et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet 1998; 20 (2): 129–35. DOI: 10.1038/2424</mixed-citation><mixed-citation xml:lang="ru">Coffey A.J., Brooksbank R.A., Brandau O., Oohashi T., Howell G.R., Bye J.M., et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet 1998; 20 (2): 129–35. DOI: 10.1038/2424</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Seemayer T.A., Gross T.G., Egeler R.M., Pirruccello S.J., Davis J.R., Kelly C.M., et al. X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr Res 1995; 38 (4): 471–8. DOI: 10.1203/00006450-199510000-00001</mixed-citation><mixed-citation xml:lang="ru">Seemayer T.A., Gross T.G., Egeler R.M., Pirruccello S.J., Davis J.R., Kelly C.M., et al. X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr Res 1995; 38 (4): 471–8. DOI: 10.1203/00006450-199510000-00001</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Роппельт А.А., Юхачева Д.В., Мякова Н.В., Смирнова Н.В., Скворцова Ю.В., Варламова Т.В. и др. Х-сцепленный лимфопролиферативный синдром 1-го и 2-го типов. Вопросы гематологии/онкологии и иммунологии в педиатрии 2016; 15 (1): 17–26.</mixed-citation><mixed-citation xml:lang="ru">Роппельт А.А., Юхачева Д.В., Мякова Н.В., Смирнова Н.В., Скворцова Ю.В., Варламова Т.В. и др. Х-сцепленный лимфопролиферативный синдром 1-го и 2-го типов. Вопросы гематологии/онкологии и иммунологии в педиатрии 2016; 15 (1): 17–26.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Booth C., Gilmour K.C., Veys P., Gennery A.R., Slatter M.A., Chapel H., et al. X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease. Blood 2011; 117 (1): 53–62. DOI: 10.1182/blood-2010-06-284935</mixed-citation><mixed-citation xml:lang="ru">Booth C., Gilmour K.C., Veys P., Gennery A.R., Slatter M.A., Chapel H., et al. X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease. Blood 2011; 117 (1): 53–62. DOI: 10.1182/blood-2010-06-284935</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Jin Y., Zhou W., Tiana Z., Chen T. Variable clinical phenotypes of X-linked lymphoproliferative syndrome in China: Report of five cases with three novel mutations and review of the literature. Hum Immunol 2016; 77 (8): 658–66. DOI: 10.1016/j.humimm.2016.06.005</mixed-citation><mixed-citation xml:lang="ru">Jin Y., Zhou W., Tiana Z., Chen T. Variable clinical phenotypes of X-linked lymphoproliferative syndrome in China: Report of five cases with three novel mutations and review of the literature. Hum Immunol 2016; 77 (8): 658–66. DOI: 10.1016/j.humimm.2016.06.005</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Baranski B., Armstrong G., Truman J.T., Quinnan G.V. Jr, Straus S.E., Young N.S. Epstein–Barr virus in the bone marrow of patients with aplastic anemia. Ann Intern Med 1989; 109 (9): 695–704. DOI: 10.7326/0003-4819-109-9-695</mixed-citation><mixed-citation xml:lang="ru">Baranski B., Armstrong G., Truman J.T., Quinnan G.V. Jr, Straus S.E., Young N.S. Epstein–Barr virus in the bone marrow of patients with aplastic anemia. Ann Intern Med 1989; 109 (9): 695–704. DOI: 10.7326/0003-4819-109-9-695</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Wang Y., Yagasaki H., Hama A., Nishio N., Takahashi Y., Kojima S. Mutation of SBDS and SH2D1A isnot associated with aplastic anemia in Japanese children. Haematologica 2007; 92 (11): 1573. DOI: 10.3324/haematol.11568</mixed-citation><mixed-citation xml:lang="ru">Wang Y., Yagasaki H., Hama A., Nishio N., Takahashi Y., Kojima S. Mutation of SBDS and SH2D1A isnot associated with aplastic anemia in Japanese children. Haematologica 2007; 92 (11): 1573. DOI: 10.3324/haematol.11568</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Verhelst H., Van Coster R., Bockaert N., Laureys G., Latour S., Fischer A., Haerynck F. Limbic encephalitis as presentation of a SAP deficiency. Neurology 2007; 69 (2): 218–9. DOI: 10.1212/01.wnl.0000265597.56202.6c</mixed-citation><mixed-citation xml:lang="ru">Verhelst H., Van Coster R., Bockaert N., Laureys G., Latour S., Fischer A., Haerynck F. Limbic encephalitis as presentation of a SAP deficiency. Neurology 2007; 69 (2): 218–9. DOI: 10.1212/01.wnl.0000265597.56202.6c</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Neves J.F., Raga L.T., Chiang S.C., Tesi B., Vieira J.P., Cordeiro A.I., et al. Fatal Central Nervous System Lymphocytic Vasculitis after Treatment for Burkitt Lymphoma in a Patient with a SH2D1A Mutation. Pediatr Infect Dis J 2019; 38 (2): е29–31. DOI: 10.1097/INF.0000000000002154</mixed-citation><mixed-citation xml:lang="ru">Neves J.F., Raga L.T., Chiang S.C., Tesi B., Vieira J.P., Cordeiro A.I., et al. Fatal Central Nervous System Lymphocytic Vasculitis after Treatment for Burkitt Lymphoma in a Patient with a SH2D1A Mutation. Pediatr Infect Dis J 2019; 38 (2): е29–31. DOI: 10.1097/INF.0000000000002154</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Blackburn P., Lin W., Miller D.A., Lorenzo-Betancor O., Edwards E.S., Zimmermann M.T., et al. X-Linked Lymphoproliferative Syndrome Presenting as Adult-Onset Multi-Infarct Dementia. J Neuropathol Exp Neurol 2019; 78 (5): 460– 6. DOI: 10.1093/jnen/nlz018</mixed-citation><mixed-citation xml:lang="ru">Blackburn P., Lin W., Miller D.A., Lorenzo-Betancor O., Edwards E.S., Zimmermann M.T., et al. X-Linked Lymphoproliferative Syndrome Presenting as Adult-Onset Multi-Infarct Dementia. J Neuropathol Exp Neurol 2019; 78 (5): 460– 6. DOI: 10.1093/jnen/nlz018</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. Zhu J., Zhang Y., Zhen Z., Chen Y., Wang J., Cai R., Sun X. Lymphoma and cerebral vasculitis in association with X-linked lymphoproliferative disease. Chin J Cancer 2013; 32 (12): 673–7. DOI: 10.5732/cjc.012.10238</mixed-citation><mixed-citation xml:lang="ru">Zhu J., Zhang Y., Zhen Z., Chen Y., Wang J., Cai R., Sun X. Lymphoma and cerebral vasculitis in association with X-linked lymphoproliferative disease. Chin J Cancer 2013; 32 (12): 673–7. DOI: 10.5732/cjc.012.10238</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12. Dutz J., Benoit L., Wang X., Demetrick D.J., Junker A., de Sa D., Tan R. Lymphocytic vasculitis in X-linked lymphoproliferative disease. Blood 2001; 97 (1): 95–100. DOI: 10.1182/blood.v97.1.95</mixed-citation><mixed-citation xml:lang="ru">Dutz J., Benoit L., Wang X., Demetrick D.J., Junker A., de Sa D., Tan R. Lymphocytic vasculitis in X-linked lymphoproliferative disease. Blood 2001; 97 (1): 95–100. DOI: 10.1182/blood.v97.1.95</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">13. Kanegane H., Ito Y., Ohshima K., Shichijo T., Tomimasu K., Nomura K., et al. X-Linked Lymphoproliferative Syndrome Presenting With Systemic Lymphocytic Vasculitis. Am J Hematol 2005; 78: 130–3. DOI: 10.1002/ajh.20261</mixed-citation><mixed-citation xml:lang="ru">Kanegane H., Ito Y., Ohshima K., Shichijo T., Tomimasu K., Nomura K., et al. X-Linked Lymphoproliferative Syndrome Presenting With Systemic Lymphocytic Vasculitis. Am J Hematol 2005; 78: 130–3. DOI: 10.1002/ajh.20261</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">14. Talaat K., Rothman J., Cohen J., Santi M., Rorke-Adams L., Choi J., et al. Lymphocytic Vasculitis Involving the Central Nervous System Occurs in Patients with X-linked Lymphoproliferative Disease in the Absence of Epstein-Barr Virus Infection. Pediatr Blood Cancer 2009; 53 (6): 1120–3. DOI: 10.1002/pbc.22185</mixed-citation><mixed-citation xml:lang="ru">Talaat K., Rothman J., Cohen J., Santi M., Rorke-Adams L., Choi J., et al. Lymphocytic Vasculitis Involving the Central Nervous System Occurs in Patients with X-linked Lymphoproliferative Disease in the Absence of Epstein-Barr Virus Infection. Pediatr Blood Cancer 2009; 53 (6): 1120–3. DOI: 10.1002/pbc.22185</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">15. Filipovich A., Kejian Zhang K., Snow A., Marsh R.A. X-linked lymphoproliferative syndromes: brothers or distant cousins? Blood 2010; 116 (18): 3398–408. DOI: 10.1182/blood-2010-03-275909</mixed-citation><mixed-citation xml:lang="ru">Filipovich A., Kejian Zhang K., Snow A., Marsh R.A. X-linked lymphoproliferative syndromes: brothers or distant cousins? Blood 2010; 116 (18): 3398–408. DOI: 10.1182/blood-2010-03-275909</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">16. Rougemont A., Fournet J., Martin S., de Saint-Basile G., Latour S., Primeau M., et al. Chronic Active Gastritis in X-linked Lymphoproliferative Disease. Am J Surg Pathol 2008; 32 (2): 323–8. DOI: 10.1097/PAS.0b013e318141fca1</mixed-citation><mixed-citation xml:lang="ru">Rougemont A., Fournet J., Martin S., de Saint-Basile G., Latour S., Primeau M., et al. Chronic Active Gastritis in X-linked Lymphoproliferative Disease. Am J Surg Pathol 2008; 32 (2): 323–8. DOI: 10.1097/PAS.0b013e318141fca1</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">17. Mejstríková E., Janda A., Hrusák O., Bucková H. Skin Lesions in a Boy With X-linked Lymphoproliferative Disorder: Comparison of 5 SH2D1A Deletion Cases. Pediatrics 2012; 129 (2): 523–8. DOI: 10.1542/peds.2011-0870</mixed-citation><mixed-citation xml:lang="ru">Mejstríková E., Janda A., Hrusák O., Bucková H. Skin Lesions in a Boy With X-linked Lymphoproliferative Disorder: Comparison of 5 SH2D1A Deletion Cases. Pediatrics 2012; 129 (2): 523–8. DOI: 10.1542/peds.2011-0870</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">18. Gray P., O’Brien T., Wagle M., Tangye S., Palendira U., Roscioli T., et al. Cerebral Vasculitis in X-linked Lymphoproliferative Disease Cured by Matched Unrelated Cord Blood Transplant. J Clin Immunol. 2015; 35 (7): 604–9. DOI: 10.1007/s10875-015-0194-9</mixed-citation><mixed-citation xml:lang="ru">Gray P., O’Brien T., Wagle M., Tangye S., Palendira U., Roscioli T., et al. Cerebral Vasculitis in X-linked Lymphoproliferative Disease Cured by Matched Unrelated Cord Blood Transplant. J Clin Immunol. 2015; 35 (7): 604–9. DOI: 10.1007/s10875-015-0194-9</mixed-citation></citation-alternatives></ref></ref-list></back></article>
